"Triple negative" trang 1 - tải miễn phí từ tailieunhanh
AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer

AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer
9    83    0
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
8    64    1
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
13    40    1
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
7    52    1
Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

Outcome disparities in African American women with triple negative breast cancer: A comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
8    78    1
Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers
10    49    1
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
10    62    1
MiRNA-135b contributes to Triple Negative Breast Cancer molecular heterogeneity: Different expression profile in Basal-like versus non-Basal-like phenotypes

MiRNA-135b contributes to Triple Negative Breast Cancer molecular heterogeneity: Different expression profile in Basal-like versus non-Basal-like phenotypes
13    75    0
Anti-cancer effects of sulfasalazine and vitamin E succinate in MDA-MB 231 triple negative breast cancer cells

Anti-cancer effects of sulfasalazine and vitamin E succinate in MDA-MB 231 triple negative breast cancer cells
7    85    0
Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review

Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review
4    69    0
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
13    98    0
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147

MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
11    68    0
Cisplatin-resistant triple-negative breast cancer subtypes: Multiple mechanisms of resistance

Cisplatin-resistant triple-negative breast cancer subtypes: Multiple mechanisms of resistance
13    75    0
Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer

Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer
14    60    0
Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
12    56    0
CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy
7    69    0
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
17    78    0
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
8    85    1
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
9    66    1
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
11    68    1